BBNX Beta Bionics, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Beta Bionics, Inc. (BBNX) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on April 21, 2026, an 8-K current report filed on July 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Beta Bionics, Inc. (BBNX) (SEC CIK 1674632), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Beta Bionics, Inc.
Ask AI about BBNX filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting BBNX positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on BBNX.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate BBNX share value held by 13F filers tracked by SignalX, by quarter.
- Morgan Stanley+768.2K (+22%)
- BlackRock+124.7K (+4%)
- State Street Corp+83.0K (+10%)
- Northern Trust+11.4K (+4%)
- AQR Capital Management+9.9K (+20%)
- Two Sigma Investments345.1K (-84%)
- Bank of America Corp296.1K (-68%)
- Goldman Sachs Group284.1K (-70%)
- Citadel Advisors LLC253.7K (-77%)
- Millennium Management84.6K (-9%)
- Vanguard Group Inc−2.22M
- JPMorgan Chase & Co−348.7K
- Invesco Ltd−117.4K
- Ameriprise Financial−32.4K
- D.E. Shaw & Co−13.1K
Source: 13F-HR filings on SEC EDGAR (aggregated from 98 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest BBNX SEC filings in 2026?
Beta Bionics, Inc. (BBNX) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on April 21, 2026, an 8-K current report on July 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did BBNX file its most recent 10-K annual report?
Beta Bionics, Inc. (BBNX) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view BBNX 10-Q quarterly reports?
Beta Bionics, Inc. (BBNX)'s most recent 10-Q quarterly report was filed on April 21, 2026. SignalX displays every BBNX 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has BBNX filed recently?
Beta Bionics, Inc. (BBNX)'s most recent 8-K was filed on July 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find BBNX insider trading activity (Form 4)?
SignalX aggregates every BBNX Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does BBNX file with the SEC?
Beta Bionics, Inc. (BBNX) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new BBNX filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Beta Bionics, Inc. (BBNX).
What is BBNX's SEC CIK number?
Beta Bionics, Inc. (BBNX)'s SEC CIK (Central Index Key) number is 1674632. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1674632 to look up all BBNX filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Beta Bionics, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 13+ filings.